Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference

Published:2006-01 Issue:1 Volume:17 Page:20-28
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/17/1/20/381250/mdj078.pdf

Reference33 articles.

1. Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer. Prevention of chemotherapy and radiotherapy-induced emesis: results of Perugia Consensus Conference;Ann Oncol,1998

2. Recommendations for the use of antiemetics: evidence-based;Gralla;clinical practice guidelines. J Clin Oncol,1999

3. Proposal for classifying the acute emetogenicity of cancer chemotherapy;Hesketh;J Clin Oncol,1997

4. Potential role of the NK1 receptor antagonists in chemotherapy-induced nausea and vomiting;Hesketh;Support Care Cancer,2001

5. The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group

Cited by 273 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A simple prediction model for the risk of boron neutron capture therapy-induced nausea and vomiting in head and neck cancer;Radiotherapy and Oncology;2024-10

2. Bibliometric and visual analysis of chemotherapy-induced nausea and vomiting (2004-2023);Frontiers in Oncology;2024-04-24

3. Adherence to antiemetic guidelines in solid cancer patients receiving highly emetogenic chemotherapy in Korea;Supportive Care in Cancer;2024-02-24

4. MASCC/ESMO antiemetic guidelines: Introduction to the 2023 guidelines update;Supportive Care in Cancer;2023-12-22

5. Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents—updated MASCC/ESMO consensus recommendation;Supportive Care in Cancer;2023-12-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3